EPO Patents = 1

Forward Citations = 825

Loading Chart...

3 inventors (with patents filed for the assignee):

Malek Faham (9 out of 54 patents)

Thomas Willis (9 out of 30 patents)

Martin Moorhead (2 out of 9 patents)

9 patents: Sort by Forward Citations

1. 9228232 - Methods of monitoring conditions by sequence analysis (2016-01-05),

2. 9217176 - Methods of monitoring conditions by sequence analysis (2015-12-22),

3. 9043160 - Method of determining clonotypes and clonotype profiles (2015-05-26),

4. 8795970 - Methods of monitoring conditions by sequence analysis (2014-08-05),

5. 8748103 - Monitoring health and disease status using clonotype profiles (2014-06-10),

6. 8691510 - Sequence analysis of complex amplicons (2014-04-08),

7. 8628927 - Monitoring health and disease status using clonotype profiles (2014-01-14),

8. 8507205 - Single cell analysis by polymerase cycling assembly (2013-08-13),

9. 8236503 - Methods of monitoring conditions by sequence analysis (2012-08-07),

Sequenta, Inc. is a biotechnology company specializing in immune repertoire profiling. Their innovative technology enables high-throughput sequencing of immune receptors to provide valuable insights for precision medicine and immunotherapy development. With a strong focus on research and development, Sequenta aims to revolutionize personalized medicine by decoding immune system diversity and function.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 13 2026

9 Patents

#106 in South San Francisco, CA

#7,521 in California

#31,702 in US

South San Francisco, CA, United States of America

Sequenta, Inc.

Forward Citations = 825

3 inventors:

Malek Faham (9 out of 54 patents)

Thomas Willis (9 out of 30 patents)

Martin Moorhead (2 out of 9 patents)

Please report any incorrect information to support@idiyas.com

1 patent (EPO):

Please report any incorrect information to support@idiyas.com